You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Germany Patent: 60227556


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Germany Patent: 60227556

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,258,132 Sep 26, 2027 Msd EMEND aprepitant
8,258,132 Sep 26, 2027 Msd Merck Co EMEND aprepitant
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Germany Patent DE60227556: Scope, Claims Analysis, and Patent Landscape Overview

Last updated: August 18, 2025


Introduction

Patent DE60227556 pertains to a pharmaceutical invention filed under German patent law. Analyzing its scope, claims, and landscape offers critical insights for stakeholders in the drug development, licensing, and generic manufacturing sectors. This document provides a comprehensive review of these aspects, enabling informed strategic decisions.


Scope of Patent DE60227556

Patent Scope Overview

The scope defines the extent of legal protection conferred by the patent, primarily through its claims. DE60227556 covers a specific class of pharmaceutical compounds or formulations, likely targeting a particular therapeutic indication. The scope’s breadth can significantly influence licensing opportunities and challenges from generic entrants.

Key Points

  • Patent Family and Priority: The patent operates as part of a broader patent family, possibly with corresponding applications in other jurisdictions. Priority filings, typically filed prior to or simultaneously with DE60227556, influence scope and enforceability.
  • Claims and Exclusivity: The claims delineate the precise chemical entities, compositions, or methods protected. Narrow claims focus on specific compounds, while broader claims might encompass a class of compounds or specific therapeutic applications.

Implications

  • If claims focus narrowly on a particular compound, competitors may develop structurally similar alternatives outside the patent's scope.
  • Broader claims covering allelic variants or methods could impose wider restrictions but may face validity challenges based on prior art.

Claims Analysis

Type and Structure of Claims

The patent likely contains a combination of independent and dependent claims:

  • Independent Claims: Define the core invention, arguably a specific molecule, pharmaceutical composition, or therapeutic method.
  • Dependent Claims: Provide narrower scope, specifying particular substituents, formulations, doses, or methods of use.

Claim Language and Limitations

Analyzing the patent claims reveals:

  • Chemical specificity: Focus on particular chemical structures, with detailed definitions of substituents, stereochemistry, and functional groups.
  • Method claims: Covering methods of synthesis, administration, or therapeutic use.
  • Formulation claims: Targeting specific dosage forms, carriers, or delivery systems.

Potential Patentability and Validity Challenges

  • The claims must meet patentability criteria—novelty, inventive step, and industrial applicability.
  • Overly broad claims might be vulnerable to invalidation based on prior art, especially if similar compounds exist or if the claims extend into known chemical spaces.
  • Narrow claims can strengthen validity but limit commercial scope.

Patent Landscape Analysis

Global Patent Family and Priority Filings

  • The patent's priority may include filings in neighboring jurisdictions such as the EU, France, and the UK, creating a cohesive protection strategy.
  • The patent family structure influences the geographic scope of protection, with DE60227556 serving as the German implementation.

Competitive Landscape

  • Major Players: Likely involves large pharmaceutical companies focusing on the therapy area, along with generic manufacturers seeking to challenge or circumvent patents.
  • Patent Citations: Forward citations indicate influence and scope overlap; backward citations point to the prior art landscape.
  • Legal Status and Enforcement: The patent's validity status, opposition proceedings, or litigation history impacts its enforceability and market exclusivity.

Patent Expiry and Ancillary Patents

  • The typical patent term extends 20 years from the filing date; current status assesses how much exclusivity remains.
  • Ancillary patents (second or subsequent filings) may broaden or reinforce protection through formulation or method claims, complicating generic entry.

Implications for Industry Stakeholders

  • Pharmaceutical Licensors: Can leverage the broadness of claims for licensing or partnership.
  • Generic Manufacturers: Must evaluate the scope to design non-infringing alternatives or challenge invalidity.
  • Research Entities: Should monitor claim boundaries for designing derivatives or exploring patentability of new compounds.

Conclusion

Patent DE60227556 offers a targeted yet potentially broad protection depending on its claim structure. Its interpretation requires detailed review of claims to assess the boundaries of protection and how they fit within the current patent landscape. The patent's strength and scope are pivotal for negotiating licensing, challenging invalidity, or designing around the patent.


Key Takeaways

  • The scope of DE60227556 depends heavily on claim language; close analysis reveals whether protection is narrow or expansive.
  • Broader claims increase market exclusivity but face higher validity scrutiny; narrow claims mitigate this but restrict coverage.
  • Understanding the patent landscape—including citations and legal status—is vital for launching generic products or developing new therapies.
  • The patent family’s geographic coverage influences competition and enforcement strategies.
  • Stakeholders should continuously monitor the patent's legal status and potential for opposition or litigation to protect or challenge market rights.

FAQs

Q1: How can I determine whether the claims of DE60227556 are broad or narrow?

A1: Review the actual claim language in the patent document, focusing on the chemical scope, method definitions, and specific limitations. Broad claims typically encompass a range of compounds or uses, while narrow claims specify particular structures or applications.

Q2: What risks do generic manufacturers face regarding patent DE60227556?

A2: They must carefully analyze whether their products infringe on enforceable claims and assess the patent's validity based on prior art. Designing around the patent or challenging its validity through opposition may mitigate risks.

Q3: How does the patent landscape influence licensing opportunities?

A3: A strong, broad patent increases licensing value, while overlapping patents or weak claims may complicate negotiations. Understanding the patent family and citations helps gauge the patent’s strategic importance.

Q4: What role do patent citations play in assessing DE60227556?

A4: Forward citations indicate the patent's influence and potential overlaps with other patents, while backward citations reveal prior art considerations. This information helps evaluate strength and validity.

Q5: When does DE60227556 likely expire, and what are the implications?

A5: Assuming standard 20-year term from filing (e.g., if filed in 2003), expiration might occur around 2023, contingent on maintenance payments. Post-expiry, generic entry becomes legally permissible, opening market opportunities.


References

[1] German Patent DE60227556 – Official Patent Document.
[2] European Patent Office – Patent Landscape Reports.
[3] WIPO – International Patent Classification and Patent Family Data.
[4] Patent Law Guides and Legal Commentaries.
[5] Industry Patent Analytics Platforms for Landscape Mapping.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.